Skip to main content
OpenTrials

Clinical trial condition

Mycobacterium Infections

Explore clinical trials studying Mycobacterium Infections. Study availability and eligibility vary by location and protocol.

1,270 public trials 141 recruiting studies
Refine in advanced search Browse all conditions

Mycobacterium Infections trial results

Completed

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

NCT00000641

Conditions
Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +21 more
Locations
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
  • St. Louis ConnectCare, Infectious Diseases Clinic St Louis, Missouri, United States
  • Washington U CRS St Louis, Missouri, United States
View all 16 locations
View Trial Details
Completed

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

NCT00000796

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +25 more
Locations
  • Cook County Hosp Chicago, Illinois, United States
  • Henry Ford Hosp Detroit, Michigan, United States
  • Interfaith Med Ctr Brooklyn, New York, United States
  • SUNY / Health Sciences Ctr at Brooklyn Brooklyn, New York, United States
View all 21 locations
View Trial Details
Completed

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

NCT00000636

Conditions
AIDS-Related Complex, AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, +22 more
Locations
  • Community Consortium / UCSF San Francisco, California, United States
  • Denver CPCRA / Denver Public Hlth Denver, Colorado, United States
  • Hill Health Corp New Haven, Connecticut, United States
  • Wilmington Hosp / Med Ctr of Delaware Wilmington, Delaware, United States
View all 25 locations
View Trial Details
Completed

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

NCT00000638

Conditions
AIDS-Related Complex, AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, +22 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Hosp of Los Angeles Los Angeles, California, United States
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • Highland Gen Hosp / San Francisco Gen Hosp Oakland, California, United States
View all 76 locations
View Trial Details
Completed

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

NCT02573350

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • Beijing Chest Hospital Beijing, China
  • North Estonian Medical Centre Foundation Center of Pulmonology Tallinn, Estonia
  • Tartu University Lung Hospital Tartu, Estonia
  • State Agency of Tuberculosis and Lung Disease Riga, Latvia
View Trial Details
Completed

Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers

NCT00992069

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations
  • Ucsf Aids Crs San Francisco, California, United States
  • Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States
  • Unc Aids Crs Chapel Hill, North Carolina, United States
  • The Ohio State Univ. AIDS CRS Columbus, Ohio, United States
View Trial Details
Completed

Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children

NCT00802802

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations
  • Byramjee Jeejeebhoy Medical College (BJMC) CRS Pune, Maharashtra, India
  • Soweto IMPAACT CRS Johannesburg, Gauteng, South Africa
  • Shandukani Research CRS Johannesburg, Gauteng, South Africa
  • Durban Paediatric HIV CRS Durban, KwaZulu-Natal, South Africa
View Trial Details
Completed

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

NCT00001030

Conditions
Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +21 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
View all 42 locations
View Trial Details

Related conditions